Literature DB >> 34257429

eEF2K: an atypical kinase target for cancer.

Louisa Temme, Christopher R M Asquith.   

Abstract

Entities:  

Year:  2021        PMID： 34257429     DOI： 10.1038/d41573-021-00124-5

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Discovery of New Inhibitors of eEF2K from Traditional Chinese Medicine Based on In Silico Screening and In Vitro Experimental Validation.

Authors:  Qinghua Fu; Xiaomei Liu; Yan Li; Peng Wang; Tian Wu; Haihan Xiao; Yameng Zhao; Qichao Liao; Ziyi Song
Journal:  Molecules       Date:  2022-07-30       Impact factor: 4.927

2.  Structural basis for the calmodulin-mediated activation of eukaryotic elongation factor 2 kinase.

Authors:  Andrea Piserchio; Eta A Isiorho; Kimberly Long; Amanda L Bohanon; Eric A Kumar; Nathan Will; David Jeruzalmi; Kevin N Dalby; Ranajeet Ghose
Journal:  Sci Adv       Date:  2022-07-06       Impact factor: 14.957
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.